Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 26/74 ]
NASDAQ | Common Stock
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States.
Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas.
The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020.
Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 1, 26 | -1.11 Decreased by -2.12 K% | -0.07 Decreased by -1.56 K% |
| Mar 26, 26 | -1.34 Decreased by -2.58 K% | -1.14 Decreased by -17.20% |
| Nov 12, 25 | -0.07 Decreased by -21.74% | -0.06 Decreased by -16.67% |
| Aug 12, 25 | -0.07 Decreased by -40.00% | -0.06 Decreased by -16.67% |
| May 13, 25 | -0.05 Increased by 0.00% | -0.07 Increased by +28.57% |
| Mar 31, 25 | -0.05 Increased by +44.44% | -0.06 Increased by +21.01% |
| Nov 11, 24 | -0.06 Decreased by -15.00% | -0.06 Increased by +4.17% |
| Aug 12, 24 | -0.05 Increased by +37.50% | -0.06 Increased by +16.67% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by N/A% | -9.59 M Decreased by -42.74% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by N/A% | -10.94 M Decreased by -72.32% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -8.69 M Decreased by -20.22% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -8.42 M Decreased by -39.25% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by -100.00% | -6.72 M Decreased by -14.29% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -6.35 M Increased by +18.15% | Decreased by N/A% - |
| Sep 30, 24 | 0.00 Decreased by N/A% | -7.23 M Decreased by -16.07% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -6.05 M Increased by +38.46% | Decreased by N/A% Decreased by N/A% |